About: Herbrecht Raoul

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Herbrecht Raoul Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Person
name	Herbrecht Raoul Herbrecht R. Herbrecht R Herbrecht, Raoul
personal mailbox	raoul.herbrecht@chru-strasbourg.fr
familyName	Herbrecht
Given name	R. R Raoul
is relates of	http://hub.abes.fr/edp/periodical/therapie/2006/volume_61/issue_3/th061532/authorship/5 http://hub.abes.fr/oup/periodical/cid/1990/volume_12/issue_2/101093clinids122371/authorship/1 http://hub.abes.fr/oup/periodical/cid/2007/volume_44/issue_3/101086509917/authorship/8 http://hub.abes.fr/oup/periodical/cid/2007/volume_44/issue_3/101086510677/authorship/4 http://hub.abes.fr/oup/periodical/cid/2003/volume_36/issue_supplement3/101086367839/authorship/9 http://hub.abes.fr/oup/periodical/cid/2003/volume_36/issue_supplement3/101086367840/authorship/8 http://hub.abes.fr/oup/periodical/cid/2005/volume_40/issue_11/101086429926/authorship/1 http://hub.abes.fr/oup/periodical/cid/2008/volume_46/issue_3/101086525258/authorship/4 http://hub.abes.fr/oup/periodical/cid/2008/volume_46/issue_6/101086527383/authorship/1 http://hub.abes.fr/oup/periodical/cid/2008/volume_47/issue_9/101086592255/authorship/14 http://hub.abes.fr/oup/periodical/jid/2010/volume_202/issue_9/101086656527/authorship/7 http://hub.abes.fr/oup/periodical/jac/2004/volume_54/issue_2/101093jacdkh348/authorship/10 http://hub.abes.fr/oup/periodical/annonc/2009/volume_20/issue_12/101093annoncmdp237/authorship/10 http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_1/101093jacdkp397/authorship/6 http://hub.abes.fr/oup/periodical/cid/2004/volume_39/issue_supplement4/101086421951/authorship/4 http://hub.abes.fr/oup/periodical/cid/2006/volume_43/issue_8/101086509116/authorship/53 http://hub.abes.fr/oup/periodical/cid/2007/volume_44/issue_10/101086514341/authorship/19 http://hub.abes.fr/oup/periodical/cid/2006/volume_43/issue_8/101086507547/authorship/1 http://hub.abes.fr/oup/periodical/cid/1995/volume_21/issue_5/101093clinids2151145/authorship/2 http://hub.abes.fr/oup/periodical/cid/2000/volume_30/issue_1/101086313592/authorship/4 http://hub.abes.fr/oup/periodical/cid/2006/volume_42/issue_10/101086503425/authorship/3 http://hub.abes.fr/edp/periodical/medsci/2013/volume_29/issue_2013/medsci2013291sp19/authorship/1 http://hub.abes.fr/oup/periodical/cid/1997/volume_24/issue_1/101093clinids24141/authorship/2 http://hub.abes.fr/oup/periodical/cid/2006/volume_42/issue_7/101086500934/authorship/3 http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_12/101086598933/authorship/7 http://hub.abes.fr/oup/periodical/jac/2005/volume_56/issue_suppl1/101093jacdki223/authorship/1 http://hub.abes.fr/oup/periodical/cid/2002/volume_34/issue_5/101086324620/authorship/5 http://hub.abes.fr/edp/periodical/mbcb/2016/volume_22/issue_1/mbcb150050/authorship/5 http://hub.abes.fr/oup/periodical/annonc/1996/volume_7/issue_9/101093oxfordjournalsannonca010801/authorship/10 http://hub.abes.fr/oup/periodical/annonc/1993/volume_4/issue_8/101093oxfordjournalsannonca058619/authorship/8 http://hub.abes.fr/oup/periodical/cid/2008/volume_46/issue_12/101086588660/authorship/16 http://hub.abes.fr/oup/periodical/cid/2005/volume_40/issue_8/101086428734/authorship/5 http://hub.abes.fr/oup/periodical/jac/2003/volume_51/issue_3/101093jacdkg117/authorship/2 http://hub.abes.fr/oup/periodical/jac/2009/volume_64/issue_6/101093jacdkp355/authorship/2 http://hub.abes.fr/oup/periodical/cid/2003/volume_36/issue_supplement3/101086367837/authorship/6 http://hub.abes.fr/oup/periodical/cid/2003/volume_36/issue_2/101086345435/authorship/4 http://hub.abes.fr/oup/periodical/cid/2007/volume_44/issue_1/101086508774/authorship/10 http://hub.abes.fr/oup/periodical/cid/2007/volume_44/issue_12/101086518388/authorship/8 http://hub.abes.fr/oup/periodical/cid/2008/volume_47/issue_5/101086590566/authorship/2 http://hub.abes.fr/oup/periodical/cid/2003/volume_36/issue_supplement3/101086367838/authorship/7 http://hub.abes.fr/oup/periodical/cid/2007/volume_45/issue_5/101086520785/authorship/3 http://hub.abes.fr/oup/periodical/cid/2007/volume_45/issue_8/101086521943/authorship/5 http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_10/101086644619/authorship/3 http://hub.abes.fr/oup/periodical/trstmh/1996/volume_90/issue_3/101016s0035920396902722/authorship/1 http://hub.abes.fr/oup/periodical/cid/2005/volume_41/issue_10/101086497126/authorship/3 http://hub.abes.fr/oup/periodical/jac/1997/volume_40/issue_1/101093jac401137/authorship/1 http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_2/101093jacdkp430/authorship/7 http://hub.abes.fr/springer/periodical/15010/1990/volume_18/issue_5/B92536310D8547B0E053120B220A44EF/authorship/1 http://hub.abes.fr/springer/periodical/280/1989/volume_24/issue_5/B956F39571530ADFE053120B220AAD6A/authorship/1
is Author of	Epidemiology and Risk Factors for Gram-Positive Coccal Infections in Neutropenia: Toward a More Targeted Antibiotic Strategy Introduction the Forum Report on Advances in the Design of Antifungal Clinical Trials Prognostic Factors for Death Due to Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation: A 1-Year Retrospective Study of Consecutive Patients at French Transplantation Centers Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America The Design of Clinical Trials That Evaluate Antifungal Prophylaxis and Combination Therapy: Introduction and Overview Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen Management of systemic fungal infections: alternatives to itraconazole Interactions of Cyclosporine with Antimicrobial Agents The Safety and Efficacy of Amphotericin B Colloidal Dispersion in the Treatment of Invasive Mycoses Mycograb for the Treatment of Invasive Candidiasis Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts Invasive Aspergillosis as an Opportunistic Infection in Nonallografted Patients with Multiple Myeloma: A European Organization for Research and Treatment of Cancer Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome Forty-one recent cases of invasive zygomycosis from a global clinical registry Rare oral metastasis from a probable large-cell neuroendocrine carcinoma of the lung Cefepime/Amikacin Versus Ceftazidime/Amikacin as Empirical Therapy for Febrile Episodes in Neutropenic Patients: A Comparative Study Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial) Forum Report: Issues in Clinical Trials of Empirical Antifungal Therapy in Treating Febrile Neutropenic Patients Reply to Denning Association of Mannose-Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients Safety and efficacy of Intralipid emulsions of amphotericin B. Forum Report: Issues in the Design of Trials of Drugs for the Treatment of Invasive Aspergillosis Clinical Research in the Lay Press: Irresponsible Journalism Raises a Huge Dose of Doubt Voriconazole for Invasive Bone Aspergillosis: A Worldwide Experience of 20 Cases Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions Reply to Verweij et al An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients Reply to Wolf et al. Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis Caspofungin: the first representative of a new antifungal class A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999 http://hub.abes.fr/edp/periodical/medsci/2013/volume_29/issue_2013/medsci2013291sp19/w Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata